摘要 |
<p>The present invention relates to antagonists of human interleukin-6 that are totally incapable of binding the receptor chain responsible for transduction of the signal associated with this cytokine, that is to say with gp 130. The figure shows the lack of interaction between human interleukin-6 antagonists according to the invention and the protein gp 130.</p> |